# Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept

> **NCT04707027** · NA · UNKNOWN · sponsor: **Chiang Mai University** · enrollment: 80 (estimated)

## Conditions studied

- Polypoidal Choroidal Vasculopathy

## Interventions

- **DRUG:** Aflibercept Injection (2 mg/0.05 ml)
- **OTHER:** Defer treatment

## Key facts

- **NCT ID:** NCT04707027
- **Lead sponsor:** Chiang Mai University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2022-11
- **Final completion:** 2023-11
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04707027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04707027, "Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04707027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*